HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Coropciuc Selected Research

Bone Density Conservation Agents

3/2018Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Coropciuc Research Topics

Disease

1Osteonecrosis (Kienbock's Disease)
03/2018
1Neoplasms (Cancer)
01/2018
1Squamous Cell Carcinoma of Head and Neck
01/2018
1Renal Insufficiency (Renal Failure)
01/2018
1Diarrhea
01/2018

Drug/Important Bio-Agent (IBA)

1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2018
1Bone Density Conservation AgentsIBA
03/2018
1Tyrosine Kinase InhibitorsIBA
03/2018
1FluorineIBA
01/2018
1AfatinibIBA
01/2018
1Deoxyglucose (2 Deoxy D glucose)IBA
01/2018